Cereset Research Wearable for Brain Tumor

Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC
Brain TumorCereset Research Wearable - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will study whether the Cereset intervention can help caregivers of newly diagnosed high-grade glioma patients who are under a lot of stress. Cereset is a closed-loop acoustic stimulation intervention that has been studied in people with PTSD, insomnia, postural orthostatic tachycardia, and military veterans.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: 4 months

10 days
Number of Completed Interventions
4 months
Caregiver Interview
Changes in Heart Rate - FAROS 180 device
Generalized Anxiety Disorder 7-item scale (GAD-7)
Incidence of Adverse Events During Cereset Research Office Intervention
Insomnia Severity Index (ISI)
Perceived Stress Scale Questionnaire

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

Intervention with Ambulatory Therapy
1 of 1

Experimental Treatment

24 Total Participants · 1 Treatment Group

Primary Treatment: Cereset Research Wearable · No Placebo Group · N/A

Intervention with Ambulatory TherapyExperimental Group · 4 Interventions: Quality of Life Assessment, Questionnaire administration, Cereset Research Wearable, Stress management therapy · Intervention Types: Other, Other, Device, Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 4 months

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,172 Previous Clinical Trials
1,058,068 Total Patients Enrolled
Roy Strowd, MDPrincipal InvestigatorWake Forest University Health Sciences
6 Previous Clinical Trials
140 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there still opportunities available to join this experiment?

"Indeed, the information available on clinicaltrials.gov clearly shows that this medical trial is still active and open for recruitment. The initial posting was made on February 1st 2023 with an update occurring later in November 17th 2022. This clinical study requires 24 individuals to be recruited from a single site." - Anonymous Online Contributor

Unverified Answer

What is the upper limit of individuals participating in this clinical trial?

"Affirmative. According to clinicaltrials.gov, this clinical trial is presently in its recruitment phase and has been since February 1st of 2023 as per the last update on November 17th 2022. A total of 24 patients need to be enrolled from a single medical facility." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.